Choroid plexus–CSF system
Recent developments and clinical correlations
Abstract
The choroid plexus is a villous epithelial–endothelial vascular structure located within the ventricular system and is primarily responsible for the production of CSF. The choroid plexus–CSF system is crucial for the development, maintenance, and function of the CNS. The choroid plexus consists of a monolayer of cuboidal epithelial cells that surrounds a stromal core of connective tissue and capillaries. The choroid epithelium has a brush border consisting of microvilli; tight junctions, forming a blood–CSF barrier, join adjacent choroid epithelial cells.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Lun MP, Monuki ES, Lehtinen MK. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci 2015;16:445–457.
2.
Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev 2013;93:1847–1892.
3.
Liddelow SA. Development of the choroid plexus and blood-CSF barrier. Front Neurosci 2015;9:32.
4.
Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008;5:10.
5.
Spector R, Robert Snodgrass S, Johanson CE. A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Exp Neurol 2015;273:57–68.
6.
Strazielle N, Ghersi-Egea JF. Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol 2000;59:561–574.
7.
Emerich DF, Skinner SJ, Borlongan CV, Vasconcellos AV, Thanos CG. The choroid plexus in the rise, fall and repair of the brain. Bioessays 2005;27:262–274.
8.
Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 2011;8:3.
9.
Dziegielewska KM, Ek J, Habgood MD, Saunders NR. Development of the choroid plexus. Microsc Res Tech 2001;52:5–20.
10.
Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol 2010;119:75–88.
11.
Serot JM, Bene MC, Faure GC. Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci 2003;8:s515–s521.
12.
Redzic ZB, Segal MB. The structure of the choroid plexus and the physiology of the choroid plexus epithelium. Adv Drug Deliv Rev 2004;56:1695–1716.
13.
Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 2002;22:367–378.
14.
Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience 2004;129:957–970.
15.
Redzic ZB, Biringer J, Barnes K, et al. Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells. J Neurochem 2005;94:1420–1426.
16.
Maharaj AS, Walshe TE, Saint-Geniez M, et al. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 2008;205:491–501.
17.
Lindvall M, Edvinsson L, Owman C. Histochemical, ultrastructural, and functional evidence for a neurogenic control of CSF production from the choroid plexus. Adv Neurol 1978;20:111–120.
18.
Praetorius J. Water and solute secretion by the choroid plexus. Pflugers Arch 2007;454:1–18.
19.
Millar ID, Bruce J, Brown PD. Ion channel diversity, channel expression and function in the choroid plexuses. Cerebrospinal Fluid Res 2007;4:8.
20.
Nilsson C, Lindvall-Axelsson M, Owman C. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res Brain Res Rev 1992;17:109–138.
21.
Huang BS, Leenen FH. Mineralocorticoid actions in the brain and hypertension. Curr Hypertens Rep 2011;13:214–220.
22.
de Kloet ER, Van Acker SA, Sibug RM, et al. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 2000;57:1329–1336.
23.
Boassa D, Stamer WD, Yool AJ. Ion channel function of aquaporin-1 natively expressed in choroid plexus. J Neurosci 2006;26:7811–7819.
24.
Han ME, Kim HJ, Lee YS, et al. Regulation of cerebrospinal fluid production by caffeine consumption. BMC Neurosci 2009;10:110.
25.
Keep RF, Smith DE. Choroid plexus transport: gene deletion studies. Fluids Barriers CNS 2011;8:26.
26.
Spector R, Johanson CE. Vectorial ligand transport through mammalian choroid plexus. Pharm Res 2010;27:2054–2062.
27.
de Lange EC. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 2004;56:1793–1809.
28.
Alshehri B, D'Souza DG, Lee JY, Petratos S, Richardson SJ. The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption. J Neuroendocrinol 2015;27:303–323.
29.
Nualart F, Mack L, Garcia A, et al. Vitamin C transporters, recycling and the bystander effect in the nervous system: SVCT2 versus gluts. J Stem Cell Res Ther 2014;4:209.
30.
Grapp M, Wrede A, Schweizer M, et al. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat Commun 2013;4:2123.
31.
Abbott GW, Tai KK, Neverisky DL, et al. KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability. Sci Signal 2014;7:ra22.
32.
Ghersi-Egea JF, Strazielle N. Choroid plexus transporters for drugs and other xenobiotics. J Drug Target 2002;10:353–357.
33.
Gao B, Meier PJ. Organic anion transport across the choroid plexus. Microsc Res Tech 2001;52:60–64.
34.
Uchida Y, Zhang Z, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen. J Neurochem 2015;134:1104–1115.
35.
Redzic ZB, Malatiali SA, Grujicic D, Isakovic AJ. Expression and functional activity of nucleoside transporters in human choroid plexus. Cerebrospinal Fluid Res 2010;7:2.
36.
Alvira-Botero X, Carro EM. Clearance of amyloid-beta peptide across the choroid plexus in Alzheimer's disease. Curr Aging Sci 2010;3:219–229.
37.
Crossgrove JS, Li GJ, Zheng W. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Exp Biol Med 2005;230:771–776.
38.
Misawa T, Arima K, Mizusawa H, Satoh J. Close association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brains. Acta Neuropathol 2008;116:247–260.
39.
Lehtinen MK, Bjornsson CS, Dymecki SM, Gilbertson RJ, Holtzman DM, Monuki ES. The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy. J Neurosci 2013;33:17553–17559.
40.
Feliciano DM, Zhang S, Nasrallah CM, Lisgo SN, Bordey A. Embryonic cerebrospinal fluid nanovesicles carry evolutionarily conserved molecules and promote neural stem cell amplification. PLoS One 2014;9:e88810.
41.
Kokovay E, Wang Y, Kusek G, et al. VCAM1 is essential to maintain the structure of the SVZ niche and acts as an environmental sensor to regulate SVZ lineage progression. Cell Stem Cell 2012;11:220–230.
42.
Spatazza J, Lee HH, Di Nardo AA, et al. Choroid-plexus-derived Otx2 homeoprotein constrains adult cortical plasticity. Cell Rep 2013;3:1815–1823.
43.
Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012;12:623–635.
44.
Nathanson JA, Chun LL. Immunological function of the blood-cerebrospinal fluid barrier. Proc Natl Acad Sci USA 1989;86:1684–1688.
45.
Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012;4:147ra111.
46.
Iliff JJ, Nedergaard M. Is there a cerebral lymphatic system? Stroke 2013;44:S93–S95.
47.
Kress BT, Iliff JJ, Xia M, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014;76:845–861.
48.
Iliff JJ, Chen MJ, Plog BA, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 2014;34:16180–16193.
49.
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015;523:337–341.
50.
Symss NP, Oi S. Theories of cerebrospinal fluid dynamics and hydrocephalus: historical trend. J Neurosurg Pediatr 2013;11:170–177.
51.
Aicardi J. Aicardi syndrome. Brain Dev 2005;27:164–171.
52.
Banizs B, Pike MM, Millican CL, et al. Dysfunctional cilia lead to altered ependyma and choroid plexus function, and result in the formation of hydrocephalus. Development 2005;132:5329–5339.
53.
Swiderski RE, Agassandian K, Ross JL, Bugge K, Cassell MD, Yeaman C. Structural defects in cilia of the choroid plexus, subfornical organ and ventricular ependyma are associated with ventriculomegaly. Fluids Barriers CNS 2012;9:22.
54.
Yamasaki H, Sugino M, Ohsawa N. Possible regulation of intracranial pressure by human atrial natriuretic peptide in cerebrospinal fluid. Eur Neurol 1997;38:88–93.
55.
Hammer M, Sorensen PS, Gjerris F, Larsen K. Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. Acta Endocrinol 1982;100:211–215.
56.
Silverberg GD, Huhn S, Jaffe RA, et al. Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg 2002;97:1271–1275.
57.
Mori K, Tsutsumi K, Kurihara M, Kawaguchi T, Niwa M. Alteration of atrial natriuretic peptide receptors in the choroid plexus of rats with induced or congenital hydrocephalus. Childs Nerv Syst 1990;6:190–193.
58.
Kalani MY, Filippidis AS, Rekate HL. Hydrocephalus and aquaporins: the role of aquaporin-1. Acta Neurochir Suppl 2012;113:51–54.
59.
Spector R, Johanson CE. Choroid plexus failure in the Kearns-Sayre syndrome. Cerebrospinal Fluid Res 2010;7:14.
60.
Steinfeld R, Grapp M, Kraetzner R, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 2009;85:354–363.
61.
Grapp M, Just IA, Linnankivi T, et al. Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain 2012;135:2022–2031.
62.
Ramaekers V, Sequeira JM, Quadros EV. Clinical recognition and aspects of the cerebral folate deficiency syndromes. Clin Chem Lab Med 2013;51:497–511.
63.
Sadighi Z, Butler IJ, Koenig MK. Adult-onset cerebral folate deficiency. Arch Neurol 2012;69:778–779.
64.
Rothstein RP, Levison SW. Damage to the choroid plexus, ependyma and subependyma as a consequence of perinatal hypoxia/ischemia. Dev Neurosci 2002;24:426–436.
65.
Johanson C, Stopa E, Baird A, Sharma H. Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. J Neural Transm 2011;118:115–133.
66.
Schwerk C, Tenenbaum T, Kim KS, Schroten H. The choroid plexus: a multi-role player during infectious diseases of the CNS. Front Cell Neurosci 2015;9:80.
67.
Vercellino M, Votta B, Condello C, et al. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J Neuroimmunol 2008;199:133–141.
68.
Szmydynger-Chodobska J, Strazielle N, Gandy JR, et al. Posttraumatic invasion of monocytes across the blood-cerebrospinal fluid barrier. J Cereb Blood Flow Metab 2012;32:93–104.
69.
Marques F, Sousa JC, Sousa N, Palha JA. Blood-brain-barriers in aging and in Alzheimer's disease. Mol Neurodegener 2013;8:38.
70.
Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol 2009;118:497–504.
71.
Serot JM, Zmudka J, Jouanny P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. J Alzheimers Dis 2012;30:17–26.
72.
Krzyzanowska A, Carro E. Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approaches. Front Pharmacol 2012;3:75.
73.
Brkic M, Balusu S, Van Wonterghem E, et al. Amyloid beta oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases. J Neurosci 2015;35:12766–12778.
74.
Gonzalez-Marrero I, Gimenez-Llort L, Johanson CE, et al. Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease. Front Cell Neurosci 2015;9:17.
Information & Authors
Information
Published In
Copyright
© 2015 American Academy of Neurology.
Publication History
Published online: December 18, 2015
Published in print: January 19, 2016
Disclosure
E. Benarroch receives a stipend in his capacity as section editor of Clinical Implications of Neuroscience Research for Neurology®. Go to Neurology.org for full disclosures.
Study Funding
No targeted funding reported.
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- The Time Trajectory of Choroid Plexus Enlargement in Multiple Sclerosis, Healthcare, 12, 7, (768), (2024).https://doi.org/10.3390/healthcare12070768
- Editorial: Epilepsy and Alzheimer's disease: shared pathology, clinical presentations, and targets for treatment, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1441996
- AAV-mediated gene therapy for sialidosis, Molecular Therapy, 32, 7, (2094-2112), (2024).https://doi.org/10.1016/j.ymthe.2024.05.029
- Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers, Journal of Neuroscience Methods, 411, (110239), (2024).https://doi.org/10.1016/j.jneumeth.2024.110239
- Cerebral furin deficiency causes hydrocephalus in mice, Genes & Diseases, 11, 3, (101009), (2024).https://doi.org/10.1016/j.gendis.2023.04.037
- Choroid plexus enlargement in mild cognitive impairment on MRI: a large cohort study, European Radiology, 34, 8, (5297-5304), (2024).https://doi.org/10.1007/s00330-023-10572-9
- Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment, International Journal of Molecular Sciences, 24, 14, (11443), (2023).https://doi.org/10.3390/ijms241411443
- Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario, Biomedicines, 11, 6, (1520), (2023).https://doi.org/10.3390/biomedicines11061520
- Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1221775
- The choroid plexus: a missing link in our understanding of brain development and function, Physiological Reviews, 103, 1, (919-956), (2023).https://doi.org/10.1152/physrev.00060.2021
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.